Peripheral blood DNA methylation differences in twin pairs discordant for Alzheimer's disease.
Mikko KonkiMaia MalonzoIda K KarlssonNoora LindgrenBishwa GhimireJohannes SmolanderNoora M ScheininMiina OllikainenAsta LaihoLaura L EloTapio LönnbergMatias RöyttäNancy L PedersenJaakko KaprioHarri LähdesmäkiJuha O RinneRiikka J LundPublished in: Clinical epigenetics (2019)
DNA methylation differences can be detected in the peripheral blood of twin pairs discordant for Alzheimer's disease. These DNA methylation signatures may have value as disease markers and provide insights into the molecular mechanisms of pathogenesis. We found no evidence that the DNA methylation marks would be associated with gene expression in blood. Further studies are needed to elucidate the potential importance of the associated genes in neuronal functions and to validate the prognostic or diagnostic value of the individual marks or marker panels.